Hosted on MSN1h
Pharma Stock Roundup: NVO's Obesity Study Failure, FDA Nod to PFE, LLY
Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...
What Is Low Testosterone & What Causes It?
Low testosterone or testosterone deficiency, also known as hypogonadism, is a condition in which patients develop symptoms.
Northwest Naturals raw pet food tied to bird flu in cat; recall issued
The recall, according to a news release published Wednesday, involves Northwest Naturals' Feline Turkey Recipe raw frozen pet ...
healthday6h
Fairy Tales Help Teach Healthy Sleep Habits
Bedtime stories are a time-honored means of helping kids calm down and get a good night’s sleep.But these fairy tales ...
McKnight's Long-Term Care News8h
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
The Spokesman-Review17h
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Alaska Dispatch News17hOpinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
MyNewsLA18h
Ex-Cedars Sinai Worker to Arbitrate Age, Disability Discrimination Suit
A 57-year-old man who alleges that Cedars-Sinai Medical Center fired him as a mental health worker in 2023 for reasons related to his sleep apnea must take his claims before an arbitrator rather than ...